Showing 34,667 results

Government, leadership & policy

The final push for HIV in new global development agenda

Editor's pick
Key Correspondents
13 February 2015
Hepatitis C treatment

Gilead agrees 41,000 euro hep-C drug price for 12 week treatment in Germany

Editor's pick
Reuters
13 February 2015
PrEP

Lowering the Age for HIV Prevention

Editor's pick
The Atlantic
13 February 2015
Sexually transmitted infections prevention

Pilot study suggests that PrEP for other STIs might work

News
12 February 2015
Hepatitis C treatment

Gilead expects big increase in Europeans treated with hep C drug

Editor's pick
Reuters
11 February 2015
New & experimental hepatitis C treatment

FDA revokes breakthrough status for BMS hep C drug

Editor's pick
Fierce Biotech
11 February 2015
HIV prevention policy

CATIE, 90-90-90 and the case for early treatment

Editor's pick
Positive Lite
11 February 2015
HIV prevention policy

Changing the Narrative: Why HIV prevention work in Canada needs to embrace HIV treatment

Editor's pick
CATIE
11 February 2015
New & experimental hepatitis C treatment

Regulus Therapeutics reports top-line results from RG-101 clinical study for HCV treatment

Editor's pick
Regulus Therapeutics press release
11 February 2015
Cancer

HPV Vaccination Not Associated with Increase in Sexually Transmitted Infections

Editor's pick
JAMA press release
11 February 2015
Hepatitis C symptoms & diagnosis

Strategies for Slowing the Progression of Liver Fibrosis in Hepatitis C

Editor's pick
HCP Live
11 February 2015
Drug-resistant TB

Addressing TB and drug-resistant TB in the Eastern Ukrainian region

Editor's pick
Stop TB Partnership
11 February 2015
Pharmaceutical industry

Dutrebis, New HIV Drug, Approved by FDA, but Not Commercially Available

Editor's pick
The Body Pro
11 February 2015
Hepatitis C treatment

A more personalised approach to hepatitis C treatment may improve adherence and completion rates

News
11 February 2015
Side effects

HIV Organizations Urge Continuation of D:A:D Study

Editor's pick
Treatment Action Group
11 February 2015
HIV treatment

CROI 2015 Preview: New Research on HIV, Hepatitis C and Ebola

Editor's pick
The Body Pro
11 February 2015

Febrero de 2015

February 2015
Access to healthcare

Gilead faces challenge to European patent on pricey hep C drug

Editor's pick
Reuters
10 February 2015
Condoms & lubricant

The $755 Condom Pack Is the Latest Indignity in Venezuela

Editor's pick
Bloomberg
10 February 2015
Undetectable viral load & treatment as prevention

US: A Call for Improved HIV-Related Scientific Literacy on the Front Lines

Editor's pick
AIDSMeds
10 February 2015
New & experimental hepatitis C treatment

Promising data bodes well for all-Achillion hep C treatment

Editor's pick
Reuters
10 February 2015
Epidemiology & behaviour

amfAR Report Examines Heavy Impact of HIV/AIDS on Black Gay Men in the United States

Editor's pick
AmFAR
10 February 2015

February 2015

February 2015
New & experimental hepatitis C treatment

Achillion Achieves 100% SVR12 in Phase 2 Trial Evaluating 6-Week Combination Treatment With ACH-3102

Editor's pick
Achillion press release
9 February 2015